(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...
The action clears a path for the Department of Transportation and other federal agencies to begin fentanyl testing for federally regulated occupations like truck drivers.